用于治疗眼底疾病的富含生长因子等离子体:当前应用和未来方向的绘制
Eduardo Anitua1, Iraia Reparaz1, Mohammad H Alkhraisat2
1University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria 01007, Spain; BTI Biotechnology Institute, Vitoria, Spain.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 29, 2025
概括
血小板衍生疗法可用于治疗后部眼部疾病,改善解剖成功和功能,并几乎没有副作用. 需要进一步研究以优化这些再生疗法.
科学领域:
- 复原性眼科
- 眼底部疾病
- 血源疗法
背景情况:
- 后部部位疾病导致不可逆转的失明, 难以治疗.
- 血液制品具有抗炎,神经保护和再生的潜力.
- 富含血小板的衍生物正在成为有前途的治疗药物.
研究的目的:
- 对眼底疾病的富含血小板的衍生物进行综合证据.
- 评估各种疾病的治疗疗效,安全性和结果.
- 确定有前途的配方和未来的研究方向.
主要方法:
- 对涉及1253名患者的46项临床研究 (2019-2025) 的系统审查.
- 对结构缺陷,视网膜缩,视神经病变,AMD和血管功能障碍的血小板衍生疗法的分析.
- 包括各种施用途径:视窗内注射,下注射,上注射,下注射,眼滴和纤维素膜.
主要成果:
- 在病理方面观察到高解剖成功率和功能改善.
- 报告过渡性和轻度不良反应的发生率较低.
- 富含生长因子的等离子体 (PRGF-Endoret®) 为标准化和安全性而突出.
结论:
- 血小板衍生疗法是治疗后部部位疾病的有希望的再生方法.
- 目前的证据表明有效性和安全性,但研究异质性限制了概括性.
- 需要进一步的随机对照试验来验证疗效和优化治疗方案.
相关概念视频
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Open Angle Glaucoma: Treatment
557
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
557


